Singapore Paincare faces $350k to $450k in claims for alleged sums owed

The claims relate to services Lim Seow Yuen said she provided to the company in 2020.

Singapore Paincare said it has received letters of claim for between $350,000 and $450,000 for its alleged sums owed, according to a bourse filing.

The letters, dated 6 and 7 August, were from Lim Seow Yuen, who said she provided certain services to the company in 2020 based on “promises and assurances” allegedly made by executive director and CEO Dr Lee Mun Kam Bernard on behalf of the company.

On 11 August, Dr Lee’s lawyers denied the allegations, saying any financial arrangements with Lim were made in his “private capacity” and not on behalf of the company, and not for the company’s listing.

Lee has undertaken to indemnify the company for the claimed sums, subject to Dr Lee being given conduct of the company’s defence in respect of Lim’s alleged claims, and furnished security in respect of the same.

“Accordingly, there is no basis for Ms Lim’s claim against the company,” the medical services company said in the filing. “Dr Lee is confident that the company will succeed in its defence should Ms Lim bring proceedings.”

Singapore Paincare said it later learnt that Lim’s lawyers sent another letter on 26 August to Novus Corporate Finance and the Singapore Exchange, alleging that her claims against Dr Lee and the company exceed $1m.

No details of these claims were provided.

The Singapore Paincare board said that the receipt of the 6 and 7 August letters did not need to be disclosed, as they were not material, but decided to disclose details of the claims following the 26 August letter.

Reaching the people who run Asia's businesses is harder than it used to be.

Inboxes are crowded. Attention is short. The executives you most want to reach — the founders, CFOs, and operators who actually move budgets — are the hardest to find through the usual channels. If you're building a company, a category, or a reputation, you already know this.

We've spent twenty years building the room they read. Singapore Business Review is where senior decision makers in Singapore and across Southeast Asia come for business coverage they can't get elsewhere — in print, online, and in person at the summits and roundtables we host across seven markets.

If you have something these readers should know about — a point of view worth publishing, a product worth their attention, an event worth their time — we'd like to hear what you're trying to do.

Book a meeting

| Or download the media kit (PDF)

240,000 senior readers quarterly in print Top 1,700 Singapore companies reached

7 markets across Southeast Asia